CLBK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now: price (~17.81) is extended/overbought and sitting just below near-term resistance (R1 ~18.22), making near-term upside look limited versus downside risk.", "Options positioning is meaningfully defensive (very high put/call open interest), which conflicts with chasing the stock at current levels.", "With earnings on 2026-02-10 (after hours) and a large M&A deal in play, headline risk is elevated\u2014this is not an attractive entry for an impatient buyer."]
["Trend: Bullish structure with SMA_5 > SMA_20 > SMA_200 (uptrend intact).", "Momentum: MACD histogram positive and expanding (bullish momentum still present).", "Overbought risk: RSI(6) ~76.4, signaling the move is stretched and prone to pullback/consolidation.", "Levels: Pivot 16.99; resistance R1 18.22 then R2 18.98; support S1 15.77. At ~17.81, upside to R1 is modest while downside back to pivot/support is larger.", "Pattern-based odds: model suggests modest positive drift (next day/week/month), but the setup is less attractive given overbought conditions near resistance."]
["M&A catalyst: Columbia Financial agreed to acquire Northfield Bancorp (~$597M), aiming to create the 3rd-largest regional bank in NJ (potential scale/synergy narrative).", "Technicals remain in an uptrend (moving averages aligned bullish; MACD positive).", "Analyst note highlights openness to strategic actions (e.g., second-step conversion) as capital ratios normalize (adds optionality)."]
suggests defensiveness/hedging pressure around current levels.", "Event risk: earnings on 2026-02-10 (AH) can reprice the stock quickly; merger execution/regulatory timing to early Q3 2026 adds uncertainty.", "News overhang: shareholder-rights/fiduciary-duty investigation headlines around the deal can weigh on sentiment even if often routine."]
["Latest quarter: 2025/Q4.", "Revenue: 69.20M, up +236.87% YoY (strong top-line growth in the reported period).", "Profitability deteriorated: Net income 15.69M down -173.94% YoY; EPS 0.15 down -171.43% YoY, indicating earnings power weakened sharply despite higher revenue."]
["Most recent update (2025-11-24): Piper Sandler kept a Neutral rating and raised price target to $17 from $16.", "Implication: Wall Street view (from the provided coverage) is cautious/neutral, and the current price (~17.81) is already above the latest stated target\u2014suggesting limited perceived upside at this moment.", "Pros cited: more openness to strategic capital actions (e.g., second-step conversion). Cons implied: still not enough to warrant a Buy rating at the time."]
